CXD II
Report
- Report Number
- 1423500-2010-02329
- Event Type
- Injury
- Date Received
- August 10, 2010
- Date of Event
- July 6, 2010
- Report Date
- July 19, 2010
- Manufacturer
- BAXTER HEALTHCARE - LARGO
- Product Code
- FKX
- PMA / PMN Number
- K895673
- Adverse Event
- Yes
- Report Source
- Manufacturer report
- Reporter Location
- VA, US
- Reporter Occupation
- HEALTH PROFESSIONAL
Narratives
(B)(4). ROOT CAUSE COULD NOT BE DETERMINED. THE CURRENT LABELING WAS FOUND TO BE SUFFICIENT. BAXTER HAS CONDUCTED A TREND REVIEW AND FOUND THAT SIMILAR REPORTS HAVE BEEN RECEIVED FOR THE REPORTED CONDITION. THE ROOT CAUSE INVESTIGATION IS IN PROGRESS.
(B)(4). SAMPLE NOT AVAILABLE.
CUSTOMER ALLEGEDLY RECEIVED THE FOLLOWING RESULTS, WITH TWO DIFFERENT ROCHE METERS, WITHIN 10 MINUTES: 160 MG/DL (AVIVA) AND 325 MG/DL (ADVANTAGE) CUSTOMER STATES THAT HE WAS NOT FEELING WELL AT THE TIME OF THE READINGS. CUSTOMER TOOK APPROXIMATELY 10-11 UNITS OF HUMALOG BASED UPON THE READINGS. NO ADVERSE EVENT REPORTED. REQUESTED RETURN OF SUSPECT DEVICE AND REPLACEMENT WAS SENT.
THIS IS A SPONTANEOUS REPORT BY A NURSE FROM THE USA OF PERITONITIS IN A (B)(6) FEMALE PATIENT COINCIDENT WITH HOMECHOICE PERITONEAL DIALYSIS THERAPY. ON (B)(6) 2010, DURING A CALL WITH BAXTER CUSTOMER SERVICES, THE REPORTING NURSE STATED THAT ON (B)(6) 2010, THE PATIENT DEVELOPED PERITONITIS AND WAS HOSPITALIZED THE SAME DAY. IT WAS UNKNOWN WHETHER A PERITONEAL EFFLUENT CULTURE WAS PERFORMED. TREATMENT INFORMATION WAS NOT PROVIDED. THE CAUSE OF THE PERITONITIS WAS NOT REPORTED; HOWEVER WHEN THE NURSE WAS ASKED WHAT THE CAUSE OF THE PERITONITIS WAS DUE TO, THE NURSE REPLIED THAT THE PATIENT WAS BEING CARED FOR BY A NURSING HOME STAFF. IT WAS UNKNOWN WHETHER THE PERITONITIS RESOLVED. NO ADDITIONAL INFORMATION IS AVAILABLE.
Devices
| Seq | Brand | Generic | Product Code | Manufacturer | Model | Lot | UDI-DI |
|---|---|---|---|---|---|---|---|
| 1 | CXD II | SYSTEM, PERITONEAL, AUTOMATIC DELIVERY | FKX | BAXTER HEALTHCARE - LARGO |
Patients
| Seq | Age | Sex | Outcome | Treatment |
|---|---|---|---|---|
| 1 | 54 YR | Hospitalization| R | 1.5% LO/CAL UB 2.5L/3L DIANEAL, 1.5% LO/CAL 6L DIA |